Aspirin in the Prevention of Myocardial Infarction

April 1995
American Family Physician;4/1/1995, Vol. 51 Issue 5, p1280
Academic Journal
Reports on an article Glynn and associates by published in the December 1994 issue of `Annals of Emergency Medicine' evaluating whether the beneficial effects of aspirin in the prevention of myocardial infarction varied among participants with differing frequencies of aspirin use.


Related Articles

  • Monday morning MIs. Donaldson Jr., Robert M.; Berkowitz, Henry D. // Cortlandt Forum;7/25/95, Vol. 8 Issue 7, p77 

    Discusses the preventive effects of aspirin on myocardial infarction. Avoiding weekend absence of aspirin; Time span of antiplatelet effects of a dose of aspirin.

  • Vitamin C and myocardial infarction: The heart of the matter. Padayatty, Sebastian J.; Levine, Mark // American Journal of Clinical Nutrition;May2000, Vol. 71 Issue 5, p1027 

    Editorial. Comments on studies associating vitamin C with reduced risk of myocardial infarction. Potency of vitamin C as a water-soluble oxidant; Improvement of vasodilation and vascular reactivity; Support of the role of vitamin C in heart disease.

  • Aspirin and warfarin best for primary prevention of heart... Kmietowicz, Zosia // BMJ: British Medical Journal (International Edition);01/31/98, Vol. 316 Issue 7128, p330 

    Details the study of the Medical Research Council on the effectiveness of warfarin and aspirin on preventing heart attacks. Methodology used in the study; Findings of the study; Account on the warning given by Freek Verheught, professor from the University Hospital of Nijmegen, on aspirin and...

  • Could recommendations about aspirin prophylaxis enhance colorectal cancer screening programmes? Morgan, Gareth; Elwood, Peter // European Journal of Public Health;Dec2009, Vol. 19 Issue 6, p576 

    The article analyzes a study which examined the effectiveness of aspirin prophylaxis in enhancing colorectal cancer screening programmes. The health benefits of aspirin are noted, including reducing the risk of vascular events and myocardial infarction. The study observed that the benefits of...

  • FACT OR FICTION.  // Newsweek (Pacific Edition);10/30/2006 (Pacific Edition), Vol. 148 Issue 18, following p8 

    This article reports on a new study that suggests aspirin may harm the stomach and upper digestive tract. The article asks if the benefits of aspirin outweigh the dangers. The answer could be no because aspirin causes 150 more cases of GI complications per 1,000 people in male patients in their...

  • Aspirin for Primary Prevention of Coronary Events. Lauer, Michael S. // New England Journal of Medicine;5/9/2002, Vol. 346 Issue 19, p1468 

    Focuses on the use of aspirin for primary prevention of coronary events such as myocardial infarction, highlighted through the case vignette of a 45-year old man with a strong family history of premature heart disease. Strategies and evidence; Areas of uncertainty; Guidelines; Conclusions and...

  • Give blood, live longer. Day, Michael // New Scientist;10/17/98, Vol. 160 Issue 2156, p15 

    Focuses on research that found evidence that men who donate blood are less likely to have a heart attack than those who are not blood donors. Study at University of Kuopio, Finland, by Jukka Salonen; Description of the study; Possible selection bias; Support of earlier findings that people with...

  • Analysis of cost-effectiveness of antidyslipidemic therapy for preventing myocardial infarction... Haynes, R. Brian // Cortlandt Forum;07/25/97, Vol. 10 Issue 7, p22 

    Discusses the use of antidyslipidemic therapy for the prevention of myocardial infarction (MI) and death in the United States. Debate over the effects of lowering elevated lipids; Individual baseline risk; Risk of subsequent cardiovascular events after MI.

  • Clopidogrel in ischemic heart disease: A critical appraisal. Al-Otaiby, Mohammed A.; Al-Moghairi, Abdulrahman M. // Health (1949-4998);Mar2013, Vol. 5 Issue 3, p465 

    Aspirin and clopidogrel are the commonest dual antiplatelet agents being used in the secondary prevention of cardiovascular disease. In high risk patients with coronary heart disease, the use of aspirin was associated with a significant risk reduction of myocardial infarction, stroke and...

  • Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials Sanmuganathan, P S; Ghahramani, P; Jackson, P R; Wallis, E J; Ramsay, L E // Heart;Mar2001, Vol. 85 Issue 3, p265 

    The article presents a study which investigates the safety and benefit of aspirin used as primary prevention of coronary heart disease. The study was conducted through meta-analysis of four randomised controlled trials of aspirin. The study reveals that aspirin used in preventing coronary heart...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics